PURPOSE AND TARGET AUDIENCE

Kentucky leads the nation in lung cancer incidence and mortality rates, which are closely tied to the state's high adult smoking prevalence. Fortunately, recent years have brought new recommendations and insurance coverage for lung cancer screening, advances in lung cancer treatment, and growing survivorship resources. Given Kentucky's heavy lung cancer burden, concerted efforts are warranted to ensure that these improvements in care reach all at-risk Kentuckians. Primary care providers can play an important role in this effort. "Lung Cancer in Kentucky: Improving Patient Outcomes" educates primary care providers in Kentucky on ways to improve lung cancer care across the continuum. This online continuing education offering was developed by Kentucky Cancer Program at the University of Louisville - as part of the statewide Kentucky LEADS (Lung Cancer Education, Awareness, Detection, and Survivorship) Collaborative. It addresses lung cancer prevention through tobacco cessation, lung cancer screening with low-dose computed tomography (LDCT), shared decision-making, enhancing treatment through collaboration with specialists, and lung cancer survivorship after diagnosis. This interactive and engaging program consists of four lessons that can be completed in individual segments.

This course is designed for physicians, physician assistants, and nurse practitioners who practice in primary care settings in Kentucky.
Other providers are welcome to participate as well.

CONTINUING EDUCATION CREDIT

Physician Credit-The University of Louisville Continuing Medical Education office designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits^TM. Physicians and physician assistants should claim only the credit commensurate with the extent of their participation in the activity. A minimum aggregate score of 80 percent on all post-tests is required in order to claim CME credit.

Nurse Practitioner Credit: This activity is approved for 2.0 contact hours of continuing education by the American Association of Nurse Practitioners. Program ID 16072241. This activity was planned in accordance with AANP Accreditation Standards and Policies.

ACCREDITATION

The University of Louisville School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity was planned in accordance with AANP Accreditation Standards and Policies.

INSTRUCTIONS & REGISTRATION

The course takes approximately 1.0 - 2.5 hours. During the course you will watch narrated informational screens, video interviews, shared decision making demonstrations, and view course materials.

You must register, create a user profile, and take a pre-activity questionnaire before you are able to view the course and access the Resource Library. Once each lesson has been completed, you will take a post-test, followed by overall course evaluations, after which you will be able to generate your CME certificate. You will be able to stop the course at any point and resume later if you wish.

Principle Faculty

• Celeste T. Worth, MCHES
• • Professional Education and Training Manager
  • Kentucky Cancer Program
  • University of Louisville
• Ruth Mattingly, MPA
• • Associate Director For Special Initiatives
  • Kentucky Cancer Program
  • University of Louisville
• Morel Jones
• • LEADS Program Coordinator
  • Kentucky Cancer Program
  • University of Louisville
• Goetz Kloecker, MD, MSPH, MBA, FACP
• • Associate Professor
  • Director, Thoracic Oncology Clinic
  • Director, Hematology/Oncology Fellowship Program
  • University of Louisville
• Brigitte Danielle King, MD
• • Mount Sterling Clinic
  • Mount Sterling, Kentucky
• Barry Brian Sosnin, DO
• • Bluegrass Community Family Practice
  • Bardstown, Kentucky
• Kristin Paul, APRN
• • Associate Director
  • University of Louisville

LEARNING OBJECTIVES

At the end of the session the participant should be able to demonstrate the following knowledge and/or skills:

• Determine which patients are at high-risk for lung cancer and recommend screening using low-dose CT.
• Assess and recommend cessation resources to all tobacco users (including lung cancer patients) in every stage of readiness to quit.
• Discuss the Kentucky's problem of under-treatment of lung cancer and lung cancer treatment advances.
• Determine and arrange appropriate division of lung cancer patients' care among primary care providers and cancer specialists.
• Refer lung cancer patients and their caregivers to community-based survivorship resources, especially the Kentucky Cancer Program's Pathfinder, for support services.

HARDWARE & SOFTWARE REQUIREMENT AND COMMERCIAL SUPPORT

• High speed internet connection
• Adobe Acrobat 7.0 or higher
• Course content compatible with Windows 7 or newer, and Mac OS 10. We recommend using Internet Explorer 10 or newer, Mozilla Firefox 36 or newer, Google Chrome 40 or newer, or Safari 8 or newer. The courseware will be limited when using older browsers such as IE 8 or 9.
• Course content is compatible with iOS (8.0 or newer), Android (4.4 or newer), and Windows Mobile.

COMMERCIAL SUPPORT

No commercial support was used or received to fund this online course.

DISCLOSURES

Course Director

Connie Sorrell has received funding for contracted research from Bristol-Myers Squibb Foundation. Ms. Sorrell's contributions to the content of this course have been peer reviewed by Dr. Daniel Cogan and are determined to be free of commercial bias. Dr. Cogan has no relevant financial relationships with any commercial bias.

Course Coordinator

Celeste Worth has no relevant financial relationships with any commercial interests.

Planning Committee Members

Ruth Mattingly, Morel Jones, and Kristin Paul, APRN have no relevant financial relationships with any commercial interests.

Faculty

Celeste Worth, Ruth Mattingly, Morel Jones, Brigitte Danielle King, and Barry Brian Sosnin have no relevant financial relationships with any commercial interests. Dr. Goetz Kloecker has received speaker fees from Lilly, Bristol-Myers Squibb, Celgene, Genentech, and Boehringer Ingelheim, and consulting fees from Lilly and Novartis. Dr. Kloecker's presentation has been peer reviewed by Dr. Daniel Cogan and is determined to be free of commercial bias. Dr. Cogan has no relevant financial relationships with any commercial bias.

CME & PD Staff and Advisory Board

The CME & PD staff and Advisory Board have nothing to disclose.

ORIGINAL RELEASE/TERMINATION DATES

1. Estimated time to complete the educational activity: 1.0 - 2.5 hours
2. Course Originally Released On:: 7/22/2016
3. Date of Most Recent Review: : 7/22/2016
4. Course Termination Date: 7/22/2018

SPECIAL SERVICES AND CONTACT INFORMATION

If you need special accommodations due to a disability, or for an alternative form of course materials, please contact Morel Jones at kyleads@louisville.edu.

PROVIDER CONTACT INFORMATION

If you need support or have any questions related to obtaining CME credit, please e-mail the University of Louisville Continuing Medical Education and Professional Development program at cmepd@louisville.edu

CONTACT INFORMATION

If you have any questions about the content of this course or need assistance, please email us at kyleads@louisville.edu.

PRIVACY POLICY AND COPYRIGHT

All information provided by course participants is confidential and will not be shared with any other parties for any reason without permission.

COPYRIGHT

The University of Louisville has obtained permission from the Kentucky Cancer Program to use the content in this educational activity. If you would like to share content from this training/program, please contact Morel Jones at the Kentucky Cancer Program (kyleads@louisville.edu.).